Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

KEY INFORMATION RELATING TO THE PROPOSED UNDERWRITTEN RIGHTS ISSUE IN PCI BIOTECH HOLDING ASA

PCI Biotech Holding
Posted on: 17 Nov 16

Reference is made to the Company's announcement on 17 November 2016 regarding a underwritten rights issue proposed resolved at an extraordinary general meeting on 8 December 2016. The rights issue is subject to shareholder approval and a prospectus approved by the Norwegian Financial Supervisory Authority and published by the Company.

Key information in relation to the proposed rights issue:
Date on which the proposed terms and conditions of the rights issue were announced: 17 November 2016
Last day including right: 8 December 2016
Ex-date: 9 December 2016
Record date: 12 December 2016
Date of approval: Not yet approved. Proposed that the extraordinary general meeting to be held at 8 December 2016 approves the rights issue
Maximum number of new shares: 10,000,000 new shares
Subscription price per share: NOK 7

This information is published in accordance with the requirements of Continuing Obligations of stock exchange listed companies.

For more information visit: www.pcibiotech.com
Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo                    
Per Walday, CEO, pw@pcibiotech.no, Mobile: +47 917 93 429

  This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: PCI Biotech Holding via GlobeNewswire
HUG#2057750
GlobeNewswire
globenewswire.com

Last updated on: 18/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.